Market Tracker

02/24 5:16pm ET

Cytokinetics Inc (NASDAQ:CYTK)

10.20
Delayed Data
As of Feb 24
 +0.05 / +0.49%
Today’s Change
6.00
Today|||52-Week Range
13.45
-16.05%
Year-to-Date

Today’s Trading

Previous close10.15
Today’s open10.10
Day’s range10.05 - 10.30
Volume192,016
Average volume (3 months)307,509
Market cap$413.3M
Dividend yield--
Data as of 4:00pm ET, 02/24/2017

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-638.46%
Earnings growth (next 5 years)+1.00%
Revenue growth (last year)+271.30%
P/E ratioNM
Price/Sales4.86
Price/Book--

Competitors

 Today’s
change
Today’s
% change
NLNKNewLink Genetics Cor...-0.10-0.70%
OBSVObseva SA+0.74+5.58%
COLLCollegium Pharmaceut...+0.13+0.93%
KPTIKaryopharm Therapeut...-0.17-1.66%
Data as of 4:00pm ET, 02/24/2017

Financials

Next reporting dateApril 27, 2017
EPS forecast (this quarter)-$0.57
Annual revenue (last year)$106.4M
Annual profit (last year)$16.5M
Net profit margin15.46%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Robert I. Blum
Chief Financial Officer, Secretary &
Executive VP
Barabari Sharon A. Surrey
Corporate headquarters
South San Francisco, California

Forecasts